Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ironwood Pharmaceuticals Inc IRWD

Healthcare Biotechnology
Ironwood Pharmaceuticals, Inc. is a gastrointestinal (GI) healthcare company engaged in advancing the treatment of GI diseases and redefining the standard of care for GI patients. It is engaged in the development of LINZESS (linaclotide) for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). Linaclotide is also approved for the treatment of... see more

Recent & Breaking News (NDAQ:IRWD)

Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference

Business Wire January 6, 2014

Ironwood Pharmaceuticals Details Strategy to Establish Leading Gastrointestinal Therapeutics Company

Business Wire December 12, 2013

Ironwood Pharmaceuticals to Host Investor Day on December 12, 2013

Business Wire November 21, 2013

Ironwood Pharmaceuticals to Present at Credit Suisse 2013 Healthcare Conference

Business Wire November 6, 2013

Ironwood Pharmaceuticals Provides Third Quarter 2013 Investor Update

Business Wire October 22, 2013

Ironwood Pharmaceuticals to Host Third Quarter 2013 Investor Update Call

Business Wire October 8, 2013

Dividend Increases, Research Nominations, New Treatment Options, and Clinical Trials - Research Report on Covidien, Ironwood, ICON, Novadaq, and Antares

PR Newswire October 2, 2013

RDInvesting Provides Investors with Free In-Depth Equity Reports on EVHC, GHDX, IRWD and ROC

Accesswire September 24, 2013

Ironwood and AstraZeneca Initiate Linaclotide Phase III Trial in China for Adults with IBS-C

Business Wire September 10, 2013

Ironwood Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference

Business Wire September 3, 2013

Ironwood Pharmaceuticals Appoints Dr. Michael Hall as Senior Vice President of Clinical Development

Business Wire August 21, 2013

RDInvesting Provides Investors with Free In-Depth Equity Reports on DHI, EZCH, IRWD and NUE

Accesswire July 25, 2013

Ironwood Pharmaceuticals Provides Second Quarter 2013 Investor Update

Business Wire July 23, 2013

Ironwood Pharmaceuticals to Host Second Quarter 2013 Investor Update Call

Business Wire July 9, 2013

Innovative Technologies that Yield Improved Treatments - Research Report on Mettler-Toledo, Ironwood, Covance, Teleflex and WuXi

PR Newswire June 26, 2013

Ironwood Pharmaceuticals Announces Partial Exercise of Underwriters' Option in Public Offering of Common Stock

Business Wire June 4, 2013

Further Expansions and Positive Study Results Drive Healthcare Companies - Research Report on Agilent, Thermo Fisher, BG Medicine, Quest Diagnostics, and Ironwood Pharmaceuticals

PR Newswire May 31, 2013

Ironwood Pharmaceuticals Announces Proposed Public Offering of Common Stock

Business Wire May 20, 2013

Ironwood and Forest to Present Linaclotide Data at Digestive Disease Week® 2013

Business Wire May 14, 2013

Ironwood Pharmaceuticals to Present at Bank of America Merrill Lynch 2013 Health Care Conference

Business Wire May 7, 2013